Genetic evolutionary staging of early non–small cell lung cancer: The p53 → Her-2/neu → ras sequence
- 31 August 1999
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 118 (2) , 259-269
- https://doi.org/10.1016/s0022-5223(99)70216-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Common patterns of genetic evolution in human solid tumorsCytometry, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Preferred genetic evolutionary sequences in human breast cancer: A case studyCytometry, 1995
- Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteinsCytometry, 1992
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- The Relationship of Clinical Classification to ras p21 Expression in Human Non-Small Cell Lung CancerOncology, 1988
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976